Shaag, A., Walsh, T., Renbaum, P., Kirchhoff, T., Nafa, K., Shiovitz, S., Mandell, J.B., Welcsh, P., Lee, M.K., Ellis, N., Offit, K., Levy-Lahad, E. and King, M.C. (2005) Functional and Genomic Approaches Reveal an Ancient CHEK2 Allele Associated with Breast Cancer in the Ashkenazi Jewish Population. Human Molecular Genetics, 14, 555-563.
http://dx.doi.org/10.1093/hmg/ddi052

has been cited by the following article:

• TITLE: Effect of the R406H Substitution on the Normal Function of CHEK2

  AUTHORS: Ahmet Yilmaz, Michael E. Davis, Weiqiang Zhao

  KEYWORDS: Breast Cancer; CHEK2; Yeast; R406H; French-Canadian Women; Indian Women

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.5 No.4, March 12, 2014

  ABSTRACT: CHEK2 (Checkpoint kinase homolog 2) encodes a protein involved in pathways that arrest the cell cycle in response to genomic stress such as DNA damage or replication blocks. Carriers of some of the CHEK2 mutations are at an increased risk of breast cancer. A mutation in the kinase domain of the CHEK2 gene resulting in the R406H substitution has been reported. However, it is currently unknown whether the substitution alters the function of CHEK2 in vitro. We evaluated the effect of the R406H substitution on the normal function of CHEK2 using a yeast complementation assay. The yeast cells lacking Rad53, the yeast homologue of human CHEK2 were transformed with the wild type as well as plasmids carrying mutations resulting in the R406H, 1100delC, and S428F variants. Yeast cells carrying the R406H variant grew at a rate similar to those carrying the wild type CHEK2, whereas the yeast carrying the S428F and 1100delC mutants grew at a slower rate. These results suggest that, unlike the well-known pathogenic alleles such as 1100delC and S428F, the R406H substitution does not abrogate the function of CHEK2. Therefore, this variant is probably not important in development of breast cancer in women.